Sequence selective binding of bis-daunorubicin WP631 to DNA

被引:9
作者
Fox, KR
Webster, R
Phelps, RJ
Fokt, I
Priebe, W
机构
[1] Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2004年 / 271卷 / 17期
关键词
WP631; anthracycline antibiotic; daunorubicin; footprinting; sequence recognition;
D O I
10.1111/j.0014-2956.2004.04292.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have used footprinting techniques on a wide range of natural and synthetic footprinting substrates to examine the sequence-selective interaction of the bis-daunorubicin antibiotic WP631 with DNA. The ligand produces clear DNase I footprints that are very different from those seen with other anthracycline antibiotics such as daunorubicin and nogalamycin. Footprints are found in a diverse range of sequences, many of which are rich in GT (AC) or GA (TC) residues. As expected, the ligand binds well to the sequences CGTACG and CGATCG, but clear footprints are also found at hexanucleotide sequences such GCATGC and GCTAGC. The various footprints do not contain any particular unique di-, tri- or tetranucleotide sequences, but are frequently contain the sequence (G/C)(A/T)(A/T)(G/C). All sequences with this composition are protected by the ligand, though it can also bind to some sites that differ from this consensus by one base pair.
引用
收藏
页码:3556 / 3566
页数:11
相关论文
共 41 条
[1]   Evidence that activation of nuclear factor-κB is essential for the cytotoxic effects of doxorubicin and its analogues [J].
Ashikawa, K ;
Shishodia, S ;
Fokt, L ;
Priebe, W ;
Aggarwal, BB .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (02) :353-364
[2]  
Chaires J. B., 1996, ADV DNA SEQUENCE SPE, V2
[3]   PREFERENTIAL BINDING OF DAUNOMYCIN TO 5'ATCG AND 5'ATGC SEQUENCES REVEALED BY FOOTPRINTING TITRATION EXPERIMENTS [J].
CHAIRES, JB ;
HERRERA, JE ;
WARING, MJ .
BIOCHEMISTRY, 1990, 29 (26) :6145-6153
[4]   Structure-based design fill of a new bisintercalating anthracycline antibiotic [J].
Chaires, JB ;
Leng, FF ;
Przewloka, T ;
Fokt, I ;
Ling, YH ;
PerezSoler, R ;
Priebe, W .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (03) :261-266
[5]   Drug-DNA interactions [J].
Chaires, JB .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1998, 8 (03) :314-320
[6]   SITE AND SEQUENCE SPECIFICITY OF THE DAUNOMYCIN DNA INTERACTION [J].
CHAIRES, JB ;
FOX, KR ;
HERRERA, JE ;
BRITT, M ;
WARING, MJ .
BIOCHEMISTRY, 1987, 26 (25) :8227-8236
[7]   DETECTION OF DRUG-BINDING TO DNA BY HYDROXYL RADICAL FOOTPRINTING - RELATIONSHIP OF DISTAMYCIN BINDING-SITES TO DNA-STRUCTURE AND POSITIONED NUCLEOSOMES ON 5S RNA GENES OF XENOPUS [J].
CHURCHILL, MEA ;
HAYES, JJ ;
TULLIUS, TD .
BIOCHEMISTRY, 1990, 29 (25) :6043-6050
[8]   Sequence-specific DNA recognition by polyamides [J].
Dervan, PB ;
Bürli, RW .
CURRENT OPINION IN CHEMICAL BIOLOGY, 1999, 3 (06) :688-693
[9]   NUCLEOTIDE-SEQUENCE BINDING PREFERENCES OF NOGALAMYCIN INVESTIGATED BY DNASE-I FOOTPRINTING [J].
FOX, KR ;
WARING, MJ .
BIOCHEMISTRY, 1986, 25 (15) :4349-4356
[10]   DIETHYLPYROCARBONATE AND PERMANGANATE PROVIDE EVIDENCE FOR AN UNUSUAL DNA CONFORMATION INDUCED BY BINDING OF THE ANTITUMOUR ANTIBIOTICS BLEOMYCIN AND PHLEOMYCIN [J].
FOX, KR ;
GRIGG, GW .
NUCLEIC ACIDS RESEARCH, 1988, 16 (05) :2063-2075